CAPRICOR THERAPEUTICS, INC. (CAPR) Free cash flow 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$72.7MFY2025 · since FY2016: -$14.6M → -$72.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$72.7M | -76.7% |
| FY2024 | -$41.2M | -53.0% |
| FY2023 | -$26.9M | -1022.7% |
| FY2022 | $2.9M | +116.2% |
| FY2021 | -$18.0M | -69.8% |
| FY2020 | -$10.6M | -55.4% |
| FY2019 | -$6.8M | +51.9% |
| FY2018 | -$14.2M | +0.6% |
| FY2017 | -$14.3M | +2.6% |
| FY2016 | -$14.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net incomeCAPR Net marginCAPR Gross profitCAPR Gross marginCAPR Operating incomeCAPR Operating marginCAPR Operating cash flowCAPR Capital expendituresCAPR Return on equityCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Total liabilitiesCAPR Shareholders’ equityCAPR overview →